In an era where autoimmune and inflammatory eye disorders are gaining recognition for their profound impact on vision and quality of life, the scleritis market is experiencing a steady resurgence driven by diagnostic advancements and targeted therapies.
The global scleritis market size was valued at USD 3.39 billion in 2024 and is expected to reach USD 5.28 billion by...
เกี่ยวกับ
เงื่อนไข
ความเป็นส่วนตัว
Contact
Invest
English
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian